Rheumatoid Arthritis and Pregnancy: Planning, Management, and Delivery

Rheumatoid arthritis (RA) is a chronic autoimmune disease that most frequently affects women of childbearing age. For such patients, issues of pregnancy planning and management are particularly relevant and require a careful approach. Modern advances in understanding the interaction between pregnancy and rheumatic diseases allow women with RA to have successful pregnancy outcomes, but this requires close cooperation between a rheumatologist and an obstetrician-gynecologist [3, 6].

Pregnancy Planning in Rheumatoid Arthritis

A key aspect of a successful pregnancy in rheumatoid arthritis is thorough pre-conception planning. Specialists emphasize that the disease must be under control, meaning in a state of remission, before pregnancy occurs [1, 2, 3, 4]. An active phase of the disease in the months preceding conception significantly increases the risk of flares during pregnancy, which, in turn, can lead to adverse outcomes for the mother and fetus [3].

Preconception counseling is a mandatory stage. It includes a comprehensive assessment of the woman's health status, such as [4]:

• Assessment of disease activity.
• Identification of organ involvement.
• Analysis of the serological profile.
• Evaluation of comorbidities.

At this stage, the need to adjust current drug therapy is also discussed to ensure safety for the unborn child without allowing RA to flare. Similar recommendations apply to women with systemic lupus erythematosus (SLE) and obstetric antiphospholipid syndrome (APS), which also present unique clinical challenges during pregnancy [1, 2, 4].

The Impact of Rheumatoid Arthritis on Pregnancy

Pregnancy causes significant physiological and immunological changes in a woman's body that can affect the activity of rheumatic diseases [6]. Women with RA and SLE are at risk of disease flares during pregnancy [1, 2, 3, 4]. These flares can lead to a number of serious complications, including [1, 2, 4]:

• Preeclampsia.
• Delivery of small-for-gestational-age infants.
• Preterm birth.
• Increased risk of fetal loss.

Furthermore, chronic autoimmune diseases such as RA, SLE, and APS can affect fertility and the ability to conceive [4]. Previously, patients with rheumatic diseases were often advised against pregnancy due to concerns regarding increased maternal and fetal morbidity and mortality. However, thanks to progress in understanding the interaction between pregnancy and these diseases, as well as improvements in management methods, achieving successful pregnancy outcomes is possible today [6].

Pregnancy Management: Medications and Monitoring

Managing pregnancy in women with RA requires special attention to drug therapy. Many, but not all, antirheumatic drugs can be used during pregnancy and lactation period [1, 2]. It is important to note that the exclusion of pregnant women from clinical trials has led to a significant gap in medical knowledge regarding the use of many medications in this population. However, real-world clinical practice data helps bridge this gap [7].

Treatment goals during pregnancy include [4]:

• Preventing disease activity.
• Managing flares if they occur.
• Preventing maternal and fetal complications.

Women with obstetric APS require anticoagulant therapy during pregnancy [1, 2]. For all patients with RA and other systemic rheumatic diseases, careful clinical monitoring throughout pregnancy and the postpartum period is mandatory [4]. An integrated approach, including regular consultations with a rheumatologist and an obstetrician-gynecologist, is the key to successful pregnancy management [6].

Delivery and the Postpartum Period

Management of labor and delivery in women with rheumatoid arthritis also requires an individualized approach. Although the presented sources do not detail specific recommendations on the mode of delivery in RA, it is important that the decision is made by an interdisciplinary team of physicians taking into account disease activity, the mother's general health status, and potential obstetric complications.

The postpartum period is also a critical stage. Rheumatic disease activity may change during this time, and the risk of flares persists [3, 4]. Therefore, continuous monitoring and, if necessary, adjustment of therapy must continue after childbirth. Issues of breastfeeding and drug compatibility with lactation should also be discussed with the doctor in advance [1, 2].

Key Recommendations for Expectant Mothers

If you have been diagnosed with rheumatoid arthritis and are planning a pregnancy, follow these recommendations:

1. Plan ahead: Discuss your plans with your rheumatologist well before conception.
2. Achieve remission: Ensure your disease is under control before attempting to get pregnant.
3. Review medications: Together with your doctor, adjust your treatment regimen so that it is safe for pregnancy and lactation.
4. Regular monitoring: Strictly follow monitoring recommendations throughout pregnancy and the postpartum period.
5. Interdisciplinary approach: Ensure close cooperation between your rheumatologist and obstetrician-gynecologist.

Sources

1. Pregnancy and Management in Women with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Obstetric Antiphospholipid Syndrome. https://pubmed.ncbi.nlm.nih.gov/33589107/
2. Pregnancy and Management in Women with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Obstetric Antiphospholipid Syndrome. https://pubmed.ncbi.nlm.nih.gov/35400376/
3. The Course of Rheumatic Diseases During Pregnancy. https://pubmed.ncbi.nlm.nih.gov/31507122/
4. Reproductive Health in RA, Lupus, and APS. https://pubmed.ncbi.nlm.nih.gov/39325124/
5. Evaluation and management of systemic lupus erythematosus and rheumatoid arthritis during pregnancy. https://pubmed.ncbi.nlm.nih.gov/23773975/
6. Bridging the Pregnancy Knowledge Gap: A Real-World Analysis of Medication Use and Drug-Drug Interaction Risk in Crohn's Disease and Multiple Sclerosis. https://pubmed.ncbi.nlm.nih.gov/42601338/

The information presented in this article is for informational purposes only and cannot replace an in-person consultation with a qualified medical professional. Always consult a doctor for diagnosis and treatment.